Latvia-based Grindeks opened a new active pharmaceutical ingredient (API) manufacturing unit in Riga in June 2011.
-
Latvia-based Grindeks opened a new active pharmaceutical ingredient (API)... -
The new unit produces ursodeoxycholic acid (UDCA), which will be used in the... -
Addition of the UDCA to Grindeks' portfolio is expected to double its API... -
Grindeks produces 16 different APIs produced through multistage synthesis,...